During the past decade, J. Lewis Research, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 3 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "J. Lewis Research, Inc." are "Episodic Migraine" (2 trials), "PAR" (1 trials) and "Perennial Allergic Rhinitis" (1 trials). Many other conditions were trialed in "J. Lewis Research, Inc." in a lesser frequency.

Most popular intervention types in "J. Lewis Research, Inc." are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atogepant" (2 trials), "Placebo" (2 trials), "Ciclesonide nasal aerosol 37 mcg" (1 trials) and "ciclesonide nasal aerosol 74 mcg" (1 trials). Other intervention names were less common.

The vast majority of trials in "J. Lewis Research, Inc." are 3 trials for "All" genders.

Currently, there are NaN active trials in "J. Lewis Research, Inc.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in J. Lewis Research, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in J. Lewis Research, Inc., 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".